Proteomic analysis of the coagulation reaction in plasma and whole blood using PROTOMAP

Proteomics

Volumn 11, Issue 12, 2011, Pages 2377-2388

  Niessen, Sherry ^a   Hoover, Heather ^a   Gale, Andrew J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adipocyte plasma membrane associated protein; Biomedicine; Complement; Fc binding protein; Inflammation; Proteolysis

Indexed keywords

MEMBRANE PROTEIN; PROTEINASE;

ALGORITHM; ARTICLE; BLOOD; BLOOD CELL; BLOOD CLOTTING; CELL SURFACE; ENZYME DEGRADATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEOMICS; PROTOMAP;

BLOOD COAGULATION; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; COMPLEMENT SYSTEM PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MASS SPECTROMETRY; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PEPTIDE MAPPING; PLASMA; PROTEOMICS; SUBSTRATE SPECIFICITY; TRYPSIN;

EID: 79958150338     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000674     Document Type: Article

References (61)

1. Davie, E. W., Fujikawa, K., Kisiel, W., The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991, 30, 10363-10370.
2. Gale, A. J., Rozenshteyn, D., Cathepsin G, a leukocyte protease, activates coagulation factor VIII. Thromb. Haemost. 2008, 99, 44-51.
3. Renne, T., Pozgajova, M., Gruner, S., Schuh, K. et al., Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 2005, 202, 271-281.
4. Xu, J., Zhang, X., Pelayo, R., Monestier, M. et al., Extracellular histones are major mediators of death in sepsis. Nat. Med. 2009, 15, 1318-1321.
5. Joyce, D. E., Gelbert, L., Ciaccia, A., DeHoff, B., Grinnell, B. W., Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J. Biol. Chem. 2001, 276, 11199-11203.
6. Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., Ruf, W., Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002, 296, 1880-1882.
7. Hung, D. T., Vu, T. H., Nelken, N. A., Coughlin, S. R., Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor. J. Cell Biol. 1992, 116, 827-832.
8. Coughlin, S. R., Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 2005, 3, 1800-1814.
9. Bouma, B. N., Mosnier, L. O., Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis. Pathophysiol. Haemost. Thromb. 2003, 33, 375-381.
10. Lane, D. A., Philippou, H., Huntington, J. A., Directing thrombin. Blood 2005, 106, 2605-2612.
11. Mosnier, L. O., Zlokovic, B. V., Griffin, J. H., The cytoprotective protein C pathway. Blood 2007, 109, 3161-3172.
12. Lopez-Otin, C., Overall, C. M., Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 2002, 3, 509-519.
13. Schilling, O., Overall, C. M., Proteomic discovery of protease substrates. Curr. Opin. Chem. Biol. 2007, 11, 36-45.
14. Dix, M. M., Simon, G. M., Cravatt, B. F., Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 2008, 134, 679-691.
15. Mahrus, S., Trinidad, J. C., Barkan, D. T., Sali, A. et al., Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 2008, 134, 866-876.
16. Enoksson, M., Li, J., Ivancic, M. M., Timmer, J. C. et al., Identification of proteolytic cleavage sites by quantitative proteomics. J. Proteome Res. 2007, 6, 2850-2858.
17. Timmer, J. C., Enoksson, M., Wildfang, E., Zhu, W. et al., Profiling constitutive proteolytic events in vivo. Biochem. J. 2007, 407, 41-48.
18. McDonald, L., Robertson, D. H., Hurst, J. L., Beynon, R. J., Positional proteomics: selective recovery and analysis of N-terminal proteolytic peptides. Nat. Methods 2005, 2, 955-957.
19. Van Damme, P., Martens, L., Van, D. J., Hugelier, K., Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat. Methods 2005, 2, 771-777.
20. Mesters, R. M., Houghten, R. A., Griffin, J. H., Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. J. Biol. Chem. 1991, 266, 24514-24519.
21. Eng, J. K., McCormack, A. L., Yates, J. R., III, An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-989.
22. Hemker, H. C., Giesen, P., Al Dieria, R., Regnault, V. et al., Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol. Haemost. Thromb. 2003, 33, 4-15.
23. Gale, A. J., Heeb, M. J., Griffin, J. H., The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites. Blood 2000, 96, 585-593.
24. Dahlback, B., Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem. J. 1983, 209, 837-846.
25. Fay, P. J., Kawai, Y., Wagner, D. D., Ginsburg, D. et al., Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 1986, 232, 995-998.
26. Piersma, S. R., Broxterman, H. J., Kapci, M., de Haas, R. R. et al., Proteomics of the TRAP-induced platelet releasate. J. Proteomics 2009, 72, 91-109.
27. Eggleton, P., Tenner, A. J., Reid, K. B., C1q receptors. Clin. Exp. Immunol. 2000, 120, 406-412.
28. Ghebrehiwet, B., Peerschke, E. I., cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 2004, 41, 173-183.
29. Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D. et al., Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12, 682-687.
30. del Conde, I., Cruz, M. A., Zhang, H., Lopez, J. A., Afshar-Kharghan, V., Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 2005, 201, 871-879.
31. Kalowski, S., Howes, E. L., Jr., Margaretten, W., McKay, D. G., Effects of intravascular clotting on the activation of the complement system: the role of the platelet. Am. J. Pathol. 1975, 78, 525-536.
32. Jones, A. L., Hulett, M. D., Parish, C. R., Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol. Cell Biol. 2005, 83, 106-118.
33. Leung, L. L., Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J. Clin. Invest. 1986, 77, 1305-1311.
34. Duke-Cohan, J. S., Kim, J. H., Azouz, A., Attractin: cautionary tales for therapeutic intervention in molecules with pleiotropic functionality. J. Environ. Pathol. Toxicol. Oncol. 2004, 23, 1-11.
35. Hayward, C. P., Smith, J. W., Horsewood, P., Warkentin, T. E., Kelton, J. G., p-155, a multimeric platelet protein that is expressed on activated platelets. J. Biol. Chem. 1991, 266, 7114-7120.
36. Jeimy, S. B., Tasneem, S., Cramer, E. M., Hayward, C. P., Multimerin 1. Platelets 2008, 19, 83-95.
37. Jeimy, S. B., Fuller, N., Tasneem, S., Segers, K. et al., Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation. Thromb. Haemost. 2008, 100, 1058-1067.
38. Kobayashi, K., Ogata, H., Morikawa, M., Iijima, S. et al., Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids. Gut 2002, 51, 169-176.
39. Johansson, M. E., Thomsson, K. A., Hansson, G. C., Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J. Proteome Res. 2009, 8, 3549-3557.
40. Harada, N., Iijima, S., Kobayashi, K., Yoshida, T. et al., Human IgGFc binding protein (FcgammaBP) in colonic epithelial cells exhibits mucin-like structure. J. Biol. Chem. 1997, 272, 15232-15241.
41. Kobayashi, K., Yagasaki, M., Harada, N., Chichibu, K. et al., Detection of Fcgamma binding protein antigen in human sera and its relation with autoimmune diseases. Immunol. Lett. 2001, 79, 229-235.
42. Gazi, M. H., He, M., Cheville, J. C., Young, C. Y., Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate cancer. Cancer Biol. Ther. 2008, 7, 70-75.
43. O'Donovan, N., Fischer, A., Abdo, E. M., Simon, F. et al., Differential expression of IgG Fc binding protein (FcgammaBP) in human normal thyroid tissue, thyroid adenomas and thyroid carcinomas. J. Endocrinol. 2002, 174, 517-524.
44. Vu, T. K., Hung, D. T., Wheaton, V. I., Coughlin, S. R., Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991, 64, 1057-1068.
45. Garcia, B. A., Smalley, D. M., Cho, H., Shabanowitz, J. et al., The platelet microparticle proteome. J. Proteome Res. 2005, 4, 1516-1521.
46. Hernandez-Ruiz, L., Valverde, F., Jimenez-Nunez, M. D., Ocana, E. et al., Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J. Proteome Res. 2007, 6, 4449-4457.
47. Maynard, D. M., Heijnen, H. F., Horne, M. K., White, J. G., Gahl, W. A., Proteomic analysis of platelet alpha-granules using mass spectrometry. J. Thromb. Haemost. 2007, 5, 1945-1955.
48. Coppinger, J. A., Cagney, G., Toomey, S., Kislinger, T. et al., Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103, 2096-2104.
49. Coppinger, J. A., O'Connor, R., Wynne, K., Flanagan, M. et al., Moderation of the platelet releasate response by aspirin. Blood 2007, 109, 4786-4792.
50. Della, C. A., Maugeri, N., Pampuch, A., Cerletti, C. et al., Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008, 19, 43-50.
51. Youssef, A., Barkhan, P., Release of platelet factor 4 by adenosine diphosphate and other platelet-aggregating agents. Br. Med. J. 1968, 1, 746-747.
52. Pohl, N. M., Tong, C., Fang, W., Bi, X. et al., Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PLoS One 2009, 4, e7774.
53. Porat, A., Sagiv, Y., Elazar, Z., A 56-kDa selenium-binding protein participates in intra-Golgi protein transport. J. Biol. Chem. 2000, 275, 14457-14465.
54. Qu, D., Wang, Y., Esmon, N. L., Esmon, C. T., Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. J. Thromb. Haemost. 2007, 5, 395-402.
55. Bogner-Strauss, J. G., Prokesch, A., Sanchez-Cabo, F., Rieder, D. et al., Reconstruction of gene association network reveals a transmembrane protein required for adipogenesis and targeted by PPARgamma. Cell Mol. Life Sci. 2010, 67, 4049-4064.
56. Ilhan, A., Gartner, W., Nabokikh, A., Daneva, T. et al., Localization and characterization of the novel protein encoded by C20orf3. Biochem. J. 2008, 414, 485-495.
57. Duan, S. Z., Usher, M. G., Mortensen, R. M., PPARs: the vasculature, inflammation and hypertension. Curr. Opin. Nephrol. Hypertens. 2009, 18, 128-133.
58. Levi, M., The coagulant response in sepsis and inflammation. Hamostaseologie 2010, 30, 10-16.
59. Xu, J., Lupu, F., Esmon, C. T., Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010, 30, 5-9.
60. Markiewski, M. M., Nilsson, B., Ekdahl, K. N., Mollnes, T. E., Lambris, J. D., Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007, 28, 184-192.
61. Heeb, M. J., Rehemtulla, A., Moussalli, M., Kojima, Y., Kaufman, R. J., Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation. Eur. J. Biochem. 1999, 260, 64-75.